Literature DB >> 8957389

Simple left atrial procedure for chronic atrial fibrillation associated with mitral valve disease.

T Sueda1, H Nagata, H Shikata, K Orihashi, S Morita, M Sueshiro, K Okada, Y Matsuura.   

Abstract

BACKGROUND: A computerized 48-channel mapping system was used to investigate the characteristics of an atrial epicardial electrogram during chronic atrial fibrillation (AF) in patients with solitary mitral valve disease. We have devised a simple left atrial procedure to eliminate the chronic AF during a mitral valve operation.
METHODS: Using this mapping system, we performed intraoperative atrial mapping in 11 patients with chronic AF associated with mitral valve disease. The AF duration ranged from 0.4 to 15 years (mean, 8.0 +/- 4.5 years). A simple surgical ablation of the AF on the left atrium only was performed during the mitral valve operations.
RESULTS: The mean AF cycle length of the atria ranged from 129 to 169 milliseconds in the right atrium and from 114 to 139 milliseconds in the left atrium. The mean AF cycle length of the left atrium was shorter than that of the right atrium. Regular and repetitive activation was found in the left atria of 7 of 11 patients. The AF disappeared in all patients immediately after the operation, and 10 of these patients continued to have a sinus rhythm postoperatively (AF-free rate, 91%).
CONCLUSIONS: Computerized intraoperative mapping revealed a shorter mean AF cycle length in the left atrium. A simple left atrial procedure was effective in eliminating chronic AF associated with solitary mitral valve disease.

Entities:  

Mesh:

Year:  1996        PMID: 8957389     DOI: 10.1016/s0003-4975(96)00613-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  19 in total

1.  Regional left atrial interstitial remodeling in patients with chronic atrial fibrillation undergoing mitral-valve surgery.

Authors:  Domenico Corradi; Sergio Callegari; Stefano Benussi; Simona Nascimbene; Paolo Pastori; Simone Calvi; Roberta Maestri; Ettore Astorri; Carlo Pappone; Ottavio Alfieri
Journal:  Virchows Arch       Date:  2004-06-19       Impact factor: 4.064

2.  [A case of constrictive pericarditis with atrial fibrillation after mitral valve repair and Maze III procedure].

Authors:  H Kin; H Izumoto; K Ishibashi; J Kamata; K Kawazoe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-12

Review 3.  Surgical ablation of atrial fibrillation.

Authors:  A Marc Gillinov
Journal:  J Interv Card Electrophysiol       Date:  2005-07       Impact factor: 1.900

Review 4.  [New developments for surgical ablation of atrial fibrillation].

Authors:  W Hemmer; J O Böhm
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-06

Review 5.  Development of the Maze procedure and the contribution of Japanese surgeons.

Authors:  Shinya Takahashi; Taijiro Sueda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-11-16

Review 6.  History and development of surgical procedures for atrial fibrillation.

Authors:  Taijiro Sueda
Journal:  Surg Today       Date:  2015-03-04       Impact factor: 2.549

7.  Simultaneous Biatrial High-Density (510-512 Electrodes) Epicardial Mapping of Persistent and Long-Standing Persistent Atrial Fibrillation in Patients: New Insights Into the Mechanism of Its Maintenance.

Authors:  Seungyup Lee; Jayakumar Sahadevan; Celeen M Khrestian; Ivan Cakulev; Alan Markowitz; Albert L Waldo
Journal:  Circulation       Date:  2015-10-23       Impact factor: 29.690

Review 8.  What is essential for the elimination of persistent or chronic atrial fibrillation?

Authors:  Taijiro Sueda
Journal:  Surg Today       Date:  2013-03-24       Impact factor: 2.549

Review 9.  Surgical Ablation of Atrial Fibrillation Using Energy Sources.

Authors:  Alexandre Visconti Brick; Domingo Marcolino Braile
Journal:  Braz J Cardiovasc Surg       Date:  2015 Nov-Dec

Review 10.  Cardiac fibrillation: from ion channels to rotors in the human heart.

Authors:  Miguel Vaquero; David Calvo; José Jalife
Journal:  Heart Rhythm       Date:  2008-04-09       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.